114 related articles for article (PubMed ID: 15900936)
1. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats.
Bennett N; Papich MG; Hoenig M; Fettman MJ; Lappin MR
Am J Vet Res; 2005 Apr; 66(4):581-8. PubMed ID: 15900936
[TBL] [Abstract][Full Text] [Related]
2. Effect of glipizide on serum insulin and glucose concentrations in healthy cats.
Miller AB; Nelson RW; Kirk CA; Neal L; Feldman EC
Res Vet Sci; 1992 Mar; 52(2):177-81. PubMed ID: 1585076
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of methimazole in a novel lipophilic formulation administered transdermally to healthy cats.
Hill KE; Gieseg MA; Bridges J; Chambers JP
N Z Vet J; 2014 Jul; 62(4):208-13. PubMed ID: 24350893
[TBL] [Abstract][Full Text] [Related]
4. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation of membrane-moderated transdermal system of glipizide.
Mutalik S; Udupa N
Clin Exp Pharmacol Physiol; 2006; 33(1-2):17-26. PubMed ID: 16445694
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of glipizide after once-daily and divided doses.
Kradjan WA; Takeuchi KY; Opheim KE; Wood FC
Pharmacotherapy; 1995; 15(4):465-71. PubMed ID: 7479199
[TBL] [Abstract][Full Text] [Related]
7. Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide.
Niemi M; Backman JT; Neuvonen M; Neuvonen PJ; Kivistö KT
Clin Pharmacol Ther; 2001 Jun; 69(6):400-6. PubMed ID: 11406737
[TBL] [Abstract][Full Text] [Related]
8. Absorption of transdermal and oral cyclosporine in six healthy cats.
Miller R; Schick AE; Boothe DM; Lewis TP
J Am Anim Hosp Assoc; 2014; 50(1):36-41. PubMed ID: 24216498
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats.
Macgregor JM; Rush JE; Rozanski EA; Boothe DM; Belmonte AA; Freeman LM
Am J Vet Res; 2008 Jan; 69(1):39-44. PubMed ID: 18167085
[TBL] [Abstract][Full Text] [Related]
10. Passive and iontophoretic permeation of glipizide gel: an in vitro and in vivo study.
Ghosh B; Jain A; Ashok P; Patel B; Tarafdar K
Curr Drug Deliv; 2009 Oct; 6(5):444-50. PubMed ID: 19751199
[TBL] [Abstract][Full Text] [Related]
11. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.
Jaber LA; Ducharme MP; Halapy H
Ther Drug Monit; 1996 Feb; 18(1):6-13. PubMed ID: 8848822
[TBL] [Abstract][Full Text] [Related]
12. A transdermal delivery system for glipizide.
Ammar HO; Salama HA; Ghorab M; El-Nahhas SA; Elmotasem H
Curr Drug Deliv; 2006 Jul; 3(3):333-41. PubMed ID: 16848735
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.
Willis-Goulet HS; Schmidt BA; Nicklin CF; Marsella R; Kunkle GA; Tebbett IR
Vet Dermatol; 2003 Apr; 14(2):83-9. PubMed ID: 12662265
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.
Hoffman SB; Yoder AR; Trepanier LA
J Vet Pharmacol Ther; 2002 Jun; 25(3):189-93. PubMed ID: 12081614
[TBL] [Abstract][Full Text] [Related]
15. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats.
Nelson RW; Feldman EC; Ford SL; Roemer OP
J Am Vet Med Assoc; 1993 Sep; 203(6):821-7. PubMed ID: 8226235
[TBL] [Abstract][Full Text] [Related]
16. Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.
Geary RS; Bradley JD; Watanabe T; Kwon Y; Wedel M; van Lier JJ; VanVliet AA
Clin Pharmacokinet; 2006; 45(8):789-801. PubMed ID: 16884318
[TBL] [Abstract][Full Text] [Related]
17. Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects.
Kim NT; Cho CK; Kang P; Park HJ; Lee YJ; Bae JW; Jang CG; Lee SY
Arch Pharm Res; 2022 Feb; 45(2):114-121. PubMed ID: 34952963
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers.
Dhawan S; Singh B; Garg SK; Hota D; Dash RJ; Singla AK; Sinha VR
Clin Pharmacokinet; 2006; 45(3):317-24. PubMed ID: 16509763
[TBL] [Abstract][Full Text] [Related]
19. The effect of hyperglycemia on glipizide absorption in NIDDM patients.
Esmatjes E; Vinuesa P; Navarro P; Rodriguez-Villar C; Gomis R; Vilardell E
Diabetes Care; 1995 Jul; 18(7):1075-6. PubMed ID: 7555547
[No Abstract] [Full Text] [Related]
20. Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin.
Mutalik S; Udupa N
Pharmazie; 2002 Dec; 57(12):838-41. PubMed ID: 12561248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
